News

Tonix Pharmaceuticals Announces On-Line Publication Of Phase 3 RESILIENT Trial Results Of TNX-102 SL For Fibromyalgia In The Peer Reviewed Journal, Pain Medicine
The previously disclosed and now published RESILIENT data show that once-nightly TNX-102 SL achieved statistically significant improvement in the pri ...
J&J defeats generic drugmakers in US appeal over schizophrenia treatment
Johnson & Johnson convinced a U.S. appeals court on Tuesday to reject a bid from generic drugmakers Teva and Viatris to ...
Drug Store News1d
Lupin introduces generic Motegrity
Lupin is offering prucalopride tablets, 1 mg and 2 mg, in the United States, following the recent approval of its Abbreviated ...
BioPharma Dive2d
After delay, Kalvista wins FDA OK for drug to treat rare swelling disorder
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
US FDA approves KalVista's oral swelling disorder drug, shares rise
KalVista Pharmaceuticals said on Monday the U.S. Food and Drug Administration has approved its drug, the first on-demand oral treatment for a type of hereditary swelling disorder, sending its shares ...